Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African health sciences, 2019 - ajol.info
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …
被引用次数：46 相关文章

Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome.

B Elham, A Fawzia - African Health Sciences, 2019 - europepmc.org
Background Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …

Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome.

B Elham, A Fawzia - 2019 - cabidigitallibrary.org
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …

Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African health sciences, 2019 - pubmed.ncbi.nlm.nih.gov
Background Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …
[PDF] scienceopen.com

[PDF][PDF] Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African Health Sciences, 2019 - scienceopen.com
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …
[PDF] ajol.info

[PDF][PDF] Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African Health Sciences, 2019 - ajol.info
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …

Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African Health Sciences - bioline.org.br
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …
[HTML] nih.gov

[HTML][HTML] Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African Health Sciences, 2019 - ncbi.nlm.nih.gov
Background Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …
[PDF] researchgate.net

[PDF][PDF] Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African Health Sciences, 2019 - researchgate.net
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …
[PDF] researchgate.net

[PDF][PDF] Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: clinical characteristics, antimicrobial susceptibility and outcome

B Elham, A Fawzia - African Health Sciences, 2019 - researchgate.net
Background: Acinetobacter baumannii (AB) is increasingly becoming a clinically relevant
organism due to the rising number of associated nosocomial infections. The therapeutic …